Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions

Context

National public insurance for drugs is often based on evidence of comparative effectiveness and cost-effectiveness. This study describes how that evidence has been used across 3 jurisdictions (Australia, Canada, and Britain) that have been at the forefront of evidence-based coverage internationally.

Objectives

To describe how clinical and cost-effectiveness evidence is used in coverage decisions both within and across...